Cabozantinib-associated acquired perforating dermatosis
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_b70b79cbd6fd44cba6acb466b5330ea6 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Denis Smirnov, MD, PhD |e author |
| 700 | 1 | 0 | |a Hillary Tsibris, MD |e author |
| 245 | 0 | 0 | |a Cabozantinib-associated acquired perforating dermatosis |
| 260 | |b Elsevier, |c 2024-10-01T00:00:00Z. | ||
| 500 | |a 2352-5126 | ||
| 500 | |a 10.1016/j.jdcr.2024.06.002 | ||
| 546 | |a EN | ||
| 690 | |a acquired perforating dermatosis | ||
| 690 | |a cabozantinib | ||
| 690 | |a elastosis perforans serpiginosa | ||
| 690 | |a multikinase inhibitor | ||
| 690 | |a perforating disorder | ||
| 690 | |a tyrosine kinase inhibitor | ||
| 690 | |a Dermatology | ||
| 690 | |a RL1-803 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n JAAD Case Reports, Vol 52, Iss , Pp 38-41 (2024) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2352512624002170 | |
| 787 | 0 | |n https://doaj.org/toc/2352-5126 | |
| 856 | 4 | 1 | |u https://doaj.org/article/b70b79cbd6fd44cba6acb466b5330ea6 |z Connect to this object online. |